You are here

MBX Biosciences

Three biotechs raise $700M in rare burst of IPO activity

BioPharma Dive

Fri, 09/13/24 - 09:22 am

Bicara Therapeutics

Zenas BioPharma

MBX Biosciences

MBX aims for $136M IPO to take potential rival to Ascendis' Yorvipath into phase 3

Fierce Biotech

Mon, 09/9/24 - 07:10 pm

MBX Biosciences

MBX files for IPO, seeking cash to take challenger to Ascendis' Yorvipath into phase 3

Fierce Biotech

Mon, 08/26/24 - 10:09 am

MBX Biosciences

Ascendis Pharma